By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Domain Therapeutics 

Strasbourg      France
Phone: n/a Fax: n/a


Company News
Domain Therapeutics And Pfizer (PFE) Enter Into Collaboration Agreement On bioSensAll 4/25/2017 9:26:38 AM
Merck KGaA (MKGAF.PK) Release: Company Announces Research Collaboration With Domain Therapeutics In Immuno-Oncology 1/23/2017 9:17:31 AM
Domain Therapeutics Grants Alkermes (ALKS) A Non-Exclusive License For Its G Protein-Coupled Receptor BioSens-All Technology 12/14/2016 9:29:36 AM
Domain Therapeutics And Medicxi Launch Mavalon Therapeutics, Aimed At Halting The Progression Of Parkinson's Disease 10/18/2016 11:32:47 AM
Domain Therapeutics, Université de Montréal, Iricor And McGill University Extend Licensing And Partnership Agreement On G Protein-Coupled Receptor Biosensor Technology 9/27/2016 10:11:48 AM
Domain Therapeutics Launches Specific Purpose Vehicle Kaldi Pharma To Harness The Potential Of Its Adenosine Programs 3/4/2015 9:24:38 AM
Domain Therapeutics Appoints Professor Michel Bouvier As Chairman Of The Scientific Advisory Board 9/22/2014 9:25:02 AM
Domain Therapeutics Appoints Dr Youssef L. Bennani As Chairman Of The Board 5/27/2014 11:30:17 AM
Domain Therapeutics Continues Program To Alter Course Of Parkinson's Disease With Renewed Support By The Michael J. Fox Foundation 4/14/2014 8:34:04 AM
Domain Therapeutics Enters Into Collaboration With XOMA Corporation (XOMA) 2/4/2014 9:28:32 AM